
Natco Pharma net falls 39% on lower sales
The Hindu
Natco Pharma reported a more than 39% decline in consolidated net profit to ₹63.40 crore for the quarter ended December, in the face of lower sales and realisation from key products.
Revenue declined almost 25% to ₹386 crore.
More Related News